{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:55Z","timestamp":1761630535368},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10620-009-1047-2","type":"journal-article","created":{"date-parts":[[2009,11,30]],"date-time":"2009-11-30T17:54:11Z","timestamp":1259603651000},"page":"2514-2519","source":"Crossref","is-referenced-by-count":15,"title":["Local Immune Regulation of Mucosal Inflammation by Tacrolimus"],"prefix":"10.1007","volume":"55","author":[{"given":"Jolanda M.","family":"van Dieren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaretha E. H.","family":"Lambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst J.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janneke N.","family":"Samsom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Janneke","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward E. S.","family":"Nieuwenhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,1]]},"reference":[{"key":"1047_CR1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.MIB.0000209787.19952.53","volume":"12","author":"JM Dieren van","year":"2006","unstructured":"van Dieren JM, Kuipers EJ, Samsom JN, Nieuwenhuis EE, van der Woude CJ. Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD. Inflamm Bowel Dis. 2006;12:311\u2013327.","journal-title":"Inflamm Bowel Dis"},{"key":"1047_CR2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1046\/j.1365-2036.2003.01534.x","volume":"17","author":"DC Baumgart","year":"2003","unstructured":"Baumgart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther. 2003;17:1273\u20131281.","journal-title":"Aliment Pharmacol Ther"},{"key":"1047_CR3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1067\/mpd.2000.109193","volume":"137","author":"A Bousvaros","year":"2000","unstructured":"Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr. 2000;137:794\u2013799.","journal-title":"J Pediatr"},{"key":"1047_CR4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00054725-200209000-00002","volume":"8","author":"K Fellermann","year":"2002","unstructured":"Fellermann K, Tanko Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis. 2002;8:317\u2013324.","journal-title":"Inflamm Bowel Dis"},{"key":"1047_CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2036.2003.01662.x","volume":"18","author":"C Hogenauer","year":"2003","unstructured":"Hogenauer C, Wenzl HH, Hinterleitner TA, Petritsch W. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate\/severe ulcerative colitis. Aliment Pharmacol Ther. 2003;18:415\u2013423.","journal-title":"Aliment Pharmacol Ther"},{"key":"1047_CR6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/gut.2005.081794","volume":"55","author":"H Ogata","year":"2006","unstructured":"Ogata H, Matsui T, Nakamura M, et al. A randomised, dose-finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut. 2006;55:1255\u20131262.","journal-title":"Gut"},{"key":"1047_CR7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ibd.20644","volume":"15","author":"JM Dieren van","year":"2009","unstructured":"van Dieren JM, van Bodegraven AA, Kuipers EJ, et al. Local application of tacrolimus in distal colitis: feasible and safe. Inflamm Bowel Dis. 2009;15:193\u2013198.","journal-title":"Inflamm Bowel Dis"},{"key":"1047_CR8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1365-2036.2008.03841.x","volume":"28","author":"IC Lawrance","year":"2008","unstructured":"Lawrance IC, Copeland TS. Rectal tacrolimus in the treatment of resistant ulcerative proctitis. Aliment Pharmacol Ther. 2008;28:1214\u20131220.","journal-title":"Aliment Pharmacol Ther"},{"key":"1047_CR9","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","volume":"113","author":"IJ Fuss","year":"2004","unstructured":"Fuss IJ, Heller F, Boirivant M, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 2004;113:1490\u20131497.","journal-title":"J Clin Invest"},{"key":"1047_CR10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/intimm\/dxl030","volume":"18","author":"BA Koning de","year":"2006","unstructured":"de Koning BA, van Dieren JM, Lindenbergh-Kortleve DJ, et al. Contributions of mucosal immune cells to methotrexate-induced mucositis. Int Immunol. 2006;18:941\u2013949.","journal-title":"Int Immunol"},{"key":"1047_CR11","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.4049\/jimmunol.174.9.5279","volume":"174","author":"JN Samsom","year":"2005","unstructured":"Samsom JN, van Berkel LA, van Helvoort JM, et al. Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. J Immunol. 2005;174:5279\u20135287.","journal-title":"J Immunol"},{"key":"1047_CR12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1172\/JCI119514","volume":"100","author":"RM Hershberg","year":"1997","unstructured":"Hershberg RM, Framson PE, Cho DH, et al. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest. 1997;100:204\u2013215.","journal-title":"J Clin Invest"},{"key":"1047_CR13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1172\/JCI3201","volume":"102","author":"RM Hershberg","year":"1998","unstructured":"Hershberg RM, Cho DH, Youakim A, et al. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J Clin Invest. 1998;102:792\u2013803.","journal-title":"J Clin Invest"},{"key":"1047_CR14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1023\/A:1005499811649","volume":"45","author":"R Arya","year":"2000","unstructured":"Arya R, Grossie VB Jr, Weisbrodt NW, Lai M, Mailman D, Moody F. Temporal expression of tumor necrosis factor-alpha and nitric oxide synthase 2 in rat small intestine after endotoxin. Dig Dis Sci. 2000;45:744\u2013749.","journal-title":"Dig Dis Sci"},{"key":"1047_CR15","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/BF02208660","volume":"40","author":"Y Elitsur","year":"1995","unstructured":"Elitsur Y, Liu X, Dosescu J, Moshier JA. FK-506 and cyclosporine A (CsA) immunomodulation of the human gut mucosal immune system. Dig Dis Sci. 1995;40:1934\u20131940.","journal-title":"Dig Dis Sci"},{"key":"1047_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/ndt\/gfg594","volume":"19","author":"M Tiefenthaler","year":"2004","unstructured":"Tiefenthaler M, Hofer S, Ebner S, et al. In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression. Nephrol Dial Transplant. 2004;19:553\u2013560.","journal-title":"Nephrol Dial Transplant"},{"key":"1047_CR17","first-page":"679","volume":"87","author":"J Cos","year":"2002","unstructured":"Cos J, Villalba T, Parra R, et al. FK506 in the maturation of dendritic cells. Haematologica. 2002;87:679\u2013687.","journal-title":"Haematologica"},{"key":"1047_CR18","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2004-10-3927","volume":"105","author":"YR Lee","year":"2005","unstructured":"Lee YR, Yang IH, Lee YH, et al. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood. 2005;105:3951\u20133955.","journal-title":"Blood"},{"key":"1047_CR19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0092-8674(00)80571-1","volume":"96","author":"GR Crabtree","year":"1999","unstructured":"Crabtree GR. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell. 1999;96:611\u2013614.","journal-title":"Cell"},{"key":"1047_CR20","doi-asserted-by":"crossref","first-page":"13367","DOI":"10.1074\/jbc.273.22.13367","volume":"273","author":"CB Klee","year":"1998","unstructured":"Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 1998;273:13367\u201313370.","journal-title":"J Biol Chem"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-1047-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,24]],"date-time":"2019-02-24T17:07:23Z","timestamp":1551028043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-009-1047-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,1]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1047"],"URL":"https:\/\/doi.org\/10.1007\/s10620-009-1047-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,1]]}}}